Lilly has received additional designations for olaratumab from the FDA.
Metformin's action is generally related to the release of glucose from the liver.
Scientists are trying to find new ways to produce the nutritional fatty acids.
Multiple myeloma affects more than 30,000 Americans each year and is slightly more prevalent in men than in women.
The therapy has the ability to cross the blood-brain barrier and directly targets motor neurons affected by SMARD1.
New federal rules announced Thursday have the potential to upend the multibillion-dollar electronic cigarette industry.
A new device that slowly releases eye medication may one day be a promising option for the many glaucoma patients who struggle with administering their own daily prescription eye drops.
The new technique could lead to more precise dosing of drugs, including some potentially toxic medicines often delivered in intensive care units.
Researchers have identified a vital supply route that cancer cells use to obtain their nutrients.
The second-biggest U.S. drugmaker on Thursday nudged up its 2016 financial forecasts and its shares edged up in premarket trading.
Entresto has struggled to penetrate the chronic heart failure market, achieving dismal sales in the US since its launch in July 2015.
The formulation, indication and dosages of Trintellix remain the same as that of Brintellix.
The Food and Drug Administration issued a warning on Tuesday that reports of compulsive binge-eating, shopping, gambling, and sex have been connected to the antipsychotic Abilify.
Clinical trials by Zarate and others have shown that ketamine can lift depression in hours, or even minutes.